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Abstract  
Alcoholic hepatitis (AH) is the dramatic acute presentation of alcoholic liver disease, with a 
28-day mortality of 15% in severe cases. Research into AH has been hampered by the lack 
of effective and reproducible murine models that can be operated under different regulatory 
frameworks internationally. The liquid Lieber-deCarli (LdC) diet has been used as a means 
of ad libitum delivery of alcohol, but without an additional insult, it is associated with 
relatively mild liver injury. The transcription factor Nuclear factor-erythroid 2-related factor 2 
(Nrf2) protects against oxidative stress and mice deficient in this molecule are suggested to 
be more sensitive to alcohol-induced injury. We have established a novel model of AH in 
mice and compared the nature of liver injury in C57/BL6 wild type versus Nrf2-/- mice. Our 
data show that both WT and Nrf2-/- mice demonstrate a robust weight loss, increase in 
serum transaminase, steatosis and hepatic inflammation when exposed to diet and ethanol. 
This is accompanied by an increase in peripheral blood and hepatic myeloid cell 
populations, fibrogenic response and compensatory hepatocyte regeneration. We also noted 
characteristic disturbances in hepatic carbohydrate and lipid metabolism. Importantly use of 
Nrf2-/- mice did not increase hepatic injury responses in our hands and female wild type 
mice exhibited a more reproducible response. Thus, we have demonstrated that this simple 
murine model of AH can be used to induce an injury that recreates many of the key human 
features of alcoholic hepatitis, without the need for challenging surgical procedures to 
administer ethanol. This will be valuable for understanding of the pathogenesis of AH, for 
testing new therapeutic treatments or devising metabolic approaches to manage patients 
whilst under medical care. 
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INTRODUCTION  
Alcoholic liver disease (ALD) places an enormous burden on patients, their carers and 
society as a whole. In the last 30 years, mortality from ALD has risen by 450%(AoM., 2004), 
and in part this relates to the more dramatic, acute form of disease, alcoholic hepatitis (AH). 
There is no approved therapy for AH and whilst drugs, including immune modulators and 
monoclonal antibodies have been tested for management of severe AH, only glucocorticoids 
and pentoxyfylline have been licensed for use(European Association for the Study of, 2012). 
However, two meta-analyses of pentoxyfylline use did not show convincing benefit (Louvet 
et al., 2018; Thursz et al., 2015). Similarly whilst the large randomised, controlled STOPAH 
trial showed that corticosteroids can improve short-term survival (28 days) in patients with 
severe AH, 40% of patients were considered ‘non-responders’ (Mathurin, 2005). 
Furthermore, no significant mortality benefit was seen with steroids at 90 days or one year in 
the STOPAH trial (Thursz et al., 2015). Importantly steroids have significant side effects 
including infection(Hmoud et al., 2016), sepsis, haemorrhage and hepato-renal syndrome. 
Therefore, the UK NIHR James Lind Alliance has identified AH as a priority translational 
research area due to lack of licensed therapies. 
 Research into new therapies for AH has been disadvantaged by the lack of effective 
murine models that recreate the features of human disease whilst being reproducible and 
acceptable to local regulatory policies. The pathogenesis of AH is multifactorial, and 
characterised by macrovesicular steatosis, infiltration of immune cells, and hepatocellular 
damage accompanied by an increase in serum transaminases. The inflammatory response 
is associated with impaired hepatocyte regeneration in response to injury. Additional 
histological changes include perivenular and pericellular fibrosis.  Whilst a number of rodent 
models have been used to study AH, all have their individual challenges and deficiencies. 
Chronic ad libitum EtOH feeding using a Lieber–DeCarli (LdC) liquid diet has been widely 
tested, but generates a relatively mild injury without fibrosis when used alone(Han et al., 
2013; Hu et al., 2013; Kirpich et al., 2012; Li et al., 2014; Zhang and Meadows, 2008). A 
number of two-hit models have attempted to generate more severe injury, by combining LdC 
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diet administration with use of genetically modified mice (Ji et al., 2006; Ji et al., 2004; Ki et 
al., 2010; Ronis et al., 2015), alcohol gavage (Chang et al., 2015; Lazaro et al., 2015), and 
lipopolysaccharide (LPS)(Kong et al., 2017; Wieser et al., 2017) for example.  The National 
Institute on Alcohol Abuse and Alcoholism (NIAAA) developed a model of AH which involves 
chronic EtOH feeding in a high fat Lieber deCarli (LdC diet), followed by a single large binge 
of EtOH by gavage(Bertola et al., 2013b). This model does induce a robust neutrophil-
mediated liver injury, but the high-dose ethanol binge causes mice to become moribund, 
which is not acceptable within all regulatory systems internationally. Similarly models 
involving continuous intragastric EtOH infusion(Tsukamoto et al., 1985a) are associated with 
severe hepatic steatohepatitis and mild fibrosis, but complex surgery, single-mouse housing 
and intensive monitoring are beyond remit for many facilities and not amenable to regulatory 
drug screening.  
 
Thus simpler, less challenging models that recreate hepatic and systemic features of human 
AH are required for widespread utility. One option is to incorporate enhanced hepatic 
oxidative stress to generate a more significant injury than that generated by ethanol 
administration alone. In this context, the Nuclear factor-erythroid 2-related factor 2 (Nrf2)  
deficient mouse has been investigated. Nrf2 is s transcription factor considered the ‘master 
regulator’ of anti-oxidant defences. Lamle et al., (2008) suggested that Nrf2 knockout mice 
(Nrf2-/-) developed a more severe hepatic injury than wild-type (WT) mice given high dose 
gavage(Lamle et al., 2008). Thus we have adapted this model and describe a reproducible protocol 
that causes robust steatosis, elevation in serum transaminase levels and hepatic 
inflammation. However using this dietary protocol, we also show that use of Nrf2-/ deficient 
mice offers no advantage over female WT animals in our hands. Importantly we report 
systemic responses (weight loss, neutrophilia) and hepatic metabolic changes(Brandl et al., 
2018; Ding et al., 2019; Latchoumycandane et al., 2014) (elevated taurine, lipid 
intermediates and lactate) as well as characteristic histological features (steatosis, and 
neutrophil infiltration) that provide insight into the steatogenic mechanisms that characterise 
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AH. Thus, in conclusion we would suggest that administration of a modified LdC diet to 
female WT mice represents a tractable and simple model of alcoholic hepatitis when 
combined with daily ethanol gavage. 
 
 
METHODS  
LdC diet and ethanol feeding.  
All mice were maintained and housed under conventional conditions in the Biomedical 
Services Unit at the University of Birmingham, UK. All animal experiments were performed 
under a Home Office project license in accordance with UK legislation, and studies were 
approved by the local ethical review board. Specific pathogen free female 8-10 week old WT 
and Nrf2-/- mice on a C57/BL6J background, were obtained from the Charles Rivers 
Laboratories (Margate, U.K.; https://guide.labanimal.com/supplier/charles- river-uk-ltd).  
Female WT and Nrf2-/- mice were fed LdC liquid diet (Special Diet Services, UK) ad libitum 
for 5 days via specialised feeding tubes (Richter tubes). Preparation of the diet involved 
using a hand-held blender to mix a set volume of dry mix with maltose dextrin and water 
(See Table 1).  
 
For experimental groups LdC diet was supplemented with escalating doses of ethanol 
(Alcohol : 95% proof ethanol, William Hodgson and Company, UK) over the following week 
(2.1% ethanol on day 7 increased to 4.2% at day 9, and 6.2% at day 12).  All experimental 
mice were additionally gavaged twice daily with 33% of EtOH diluted with water from day 6 
until day 15. Prior to gavage we completed a mouse physiological condition assessment 
sheet and the volume administered to healthy animals was determined by weight (190ul for 
mice 19g, 200µl for mice 20g, 250µl for mice >25g). Control mice were fed LdC diet without 
EtOH throughout the experiment with the amount of maltodextrin adjusted to maintain total 
calorie load in both groups (see Table 1). Blood and liver tissue were collected at the end of 
the experiment. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline 
phosphatase (ALP) and bilirubin levels in murine serum as well as full blood count and 
differential were determined utilising clinical grade automated analysers at Birmingham 
Women's Hospital NHS Foundation Trust, Birmingham, UK.  
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Flow cytometry   
Liver infiltrating immune cells were isolated from freshly harvested liver lobes.  The liver was 
flushed with PBS before isolation to remove blood cells. The tissue was weighed and 
manually digested using a 70μm strainer (Falcon). The filtrate was diluted in cold RPMI and 
centrifuged twice at 700xg for 5 minutes. A working dilution of Optiprep (Sigma) at 1.09g/ml 
was obtained by mixing neat Optiprep with PBS at a 4:11 ratio. 5 ml of cell suspension was 
layered carefully over 7 ml of Optiprep solution, and centrifuged at 1000xg for 25 minutes. 
The mononuclear cells at the interface were washed twice and resuspended in PBS + 1% 
fetal calf serum. Cells were stained for 30 minutes in the dark with zombie (APC-Cy7 in a 
1:1000 concentration) to assess live/dead status of cells. Samples were washed and 
incubated for 20 minutes with purified anti-mouse CD16/32 antibody (ebioscience, clone 93, 
1:25 dilution of manufacturers stock) to block non-specific Fc- receptor binding. Finally, cells 
were incubated for 30 minutes with lineage specific antibodies for identification of myeloid 
and lymphoid cells (see Table 2). 
Immunohistochemistry and histological analysis 
Haematoxylin and eosin staining was performed on Formalin fixed, paraffin embedded 
sections from each mouse liver using standard protocols. Sections were reviewed by an 
experienced liver pathologist (SGH), blinded to the experimental conditions. For each case 
the pattern (large or small droplet), zonal distribution and severity of steatosis were 
recorded. Disease severity was scored semi-quantitatively for the overall degree of steatosis 
(0-3), the amount of large droplet steatosis (0-3), and the severity  of inflammation according 
to the Kleiner system(Kleiner et al., 2005). For antibody staining, FFPE sections were 
deparaffinised with xylene and then rehydrated through graded alcohol prior to high-
temperature antigen retrieval in pre-heated EDTA buffer (pH 8) for 15 minutes. Endogenous 
peroxidase activity was blocked (Dako-Peroxidase, Dako Ltd, Cambridge UK) for 10 
minutes, and non-specific binding of the antibodies to the sections was prevented by 
incubation with X10 casein (Vector Labs Inc Burlingame, CA, USA) diluted in PBS. Sections 
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were incubated in primary antibody, or an isotype matched control for 1 hour at room 
temperature in a humidified chamber on a rocker. They were then washed twice, followed by 
addition of the relevant horse-radish peroxidase conjugated secondary antibody for 30 
minutes and signal development using ImmPACT DAB reagent (Vector Labs). Sections 
were washed, counterstained with Mayer’s haematoxylin, dehydrated with 99% alcohol, 
cleared with xylene and then mounted in DPX (Leica GmBH). The exact conditions were 
optimised for each antibody (see Table 3). 
For image analysis, at least 5 fields of view were taken per sample using Brightfield 
microscopy with AxioScanner software at x20 magnification. The images were reviewed on 
Image J software version 1.42 (NIH). For Ki-67 staining, the number of positively staining 
hepatocytes per field was counted. For Ly6G staining, the number of positively staining cells 
was counted. For CD45 and F4/80 staining, morphometric analysis was performed. 
Picrosirius Red and Oil red O staining 
Deparaffinized, hydrated sections were placed into 5% phosphomolybdic acid solution 
(diluted in distilled water) for 5 min. Sections were washed with PBS and submerged in 0.1% 
Sirius red (Direct Red 80 dissolved in saturated picric acid solution) for 90 minutes on a 
rocker. The slides were dipped in acidified water (0.5% glacial acetic acid) for 30 seconds 
twice, followed by 100% ethanol three times for 30 seconds each. Finally staining intensity 
was determined using morphometric analysis via Image J software version 1.42 (NIH), using 
5 non-overlapping fields selected at random from each mouse (at x20 magnification). To 
quantify lipid content in hepatocytes, fresh frozen tissue sections were incubated in 60% 
isopropanol for 5minutes followed by Oil Red O reagent for 15 minutes at room temperature. 
This was tipped off and 60% isopropanol was added for another 5 minutes. Slides were 
washed twice with water and finally mounted using aqueous mountant (Thermoscientific, 
Shandon). Sections were imaged using brightfield microscopy and % staining area was 
determined using morphometric analysis via Image J software version 1.42 (NIH), using 5 
non-overlapping fields selected at random from each mouse (at x20 magnification). 
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Assessment of liver metabolism by NMR 
Single lobes from mouse livers were collected at day 13,15 and 17 for mice exposed to LdC 
plus alcohol feeding. Matched livers from mice fed control LdC diet alone were collected on 
day 17. Tissue was immediately snap frozen upon collection and stored at -80°C until 
processing.  To prepare extracts for NMR analysis, approximately 100 mg liver tissue was 
added to gentleMACs M-Tube in cold methanol (8 µL/mg) and purified water (2 µL/mg). 
Samples were homogenised using a gentleMACs homogenizer (Miltenyi, UK) and polar 
metabolites were extracted as described previously(Schofield et al., 2017) Samples were kept 
at 4°C prior to NMR. All spectra were acquired at 300 K on a Bruker 600 MHz spectrometer 
with a TCI 1.7mm z-PFG cryogenic probe using a cooled Bruker SampleJet autosampler as 
previously described (Saborano et al., 2019).1D 1H NMR spectra were processed using the 
NMRlab and Metabolab programmes within MATLAB (MathWorks, Massachusetts, USA). 
Following Fourier transformation, spectra were phased, referenced to TMSP δ 0.00 ppm, 
baseline corrected and the water region was excluded together with the edges of the spectrum 
void of signal. Lastly, spectra were scaled to the total spectral area and resonances were 
assigned using Chenomx (Alberta, Canada, 2015), and by consulting the NMR metabolic 
profiling human metabolome database (HMDB). Further details can be found in(Saborano et 
al., 2019). 
 
RESULTS  
Exposure of WT and Nrf2-/- mice to LdC diet and ethanol causes inflammation and 
hepatic steatosis with early fibrogenic change 
In order to induce a reproducible alcohol injury in mice, we modified a Lieber deCarli 
diet(Preedy et al., 1988; Wilkin et al., 2016) feeding protocol. Female WT and Nrf2-/- mice 
were fed liquid LdC diet alone for 5 days to acclimatize prior to addition of escalating doses 
of ethanol into the diet (up to a final concentration of 6.2% at day 12). Additional twice daily 
gavage with 33% of EtOH diluted with water was added from day 6 until day 15. Control 
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mice were fed LdC diet alone throughout the experiment. Whilst mean weight of the 
experimental and control groups was similar at baseline, both WT and Nrf2-/- mice lost a 
significant amount of weight after introduction of EtOH, with weight-loss approaching 20% by 
day 15 (Fig 1A). At day 15, both WT mice and Nrf2-/- exposed to LdC diet with EtOH showed 
significantly increased serum ALT levels compared to mice receiving LdC only, or normal 
chow (Fig 1B). Of note, AST levels were also significantly increased in Nrf2-/- mice receiving 
ethanol (Supp Fig 1). The AST:ALT ratio was >1, (mean AST: mean ALT was 1.63: 1 for WT 
mice and 2.53:1 for Nrf2-/- mice), but bilirubin levels were not significantly different between 
the groups (data not shown). Liver sections were scored for steatosis and inflammatory 
activity. Representative images in Figure 1A show that high fat diet alone had no effect on 
the histological changes seen in the livers of either WT or Nrf2-/- mice over the course of 15 
days. We did note that for the Nrf2-/- animals, we observed occasional fields of view where 
there was a focus of inflammatory cells or areas of macrovesicular steatosis in animals fed 
LdC alone. However, this was variable between individuals and indeed between different 
fields of view on an individual liver section, and was not significant when multiple fields of 
view were scored (Figure 1C and D). However, the addition of ethanol caused a marked 
degree of steatosis which frequently included a mixture of large and small droplets. 
Amongst, the alcohol-treated mice, the distribution of large droplet fat within hepatocytes 
was variable but steatosis overall was predominantly centrilobular in location. Semi 
quantitative scoring (Fig1C) shows the magnitude of this response. This analysis was 
confirmed using Oil red O staining (Supplemental Figure 2). As before, a mixed micro and 
macrovesicular steatosis was evident in mice (both WT and Nrf2-/-) exposed to ethanol plus 
diet, which was significantly above the background staining observed in livers from mice 
exposed to diet or chow alone. Image quantitation confirmed that steatosis was significantly 
greater in the presence of alcohol and diet feeding, and that both WT and Nrf2-/- mice 
showed a similar extent of steatosis. Importantly we did not observe hepatocyte ballooning 
or the presence of Mallory-Denk(Denk et al., 1979; Denk et al., 2000) bodies in any of the 
samples. Finally whilst there was evidence of focal inflammation in some animals, total 
inflammation scores were not significantly different between the groups (Fig 1D). In addition, 
in the groups of mice receiving ethanol, occasional mice demonstrated patches of necrosis 
on histological assessment.  
Our observations of histological sections from our injured livers (Figure 1A) suggested that 
there was a trend for increased inflammatory response induced by ethanol exposure, 
particularly in WT animals. Analysis of full blood counts (Figure 2A) showed a significant 
increase in the proportion of neutrophils and monocytes in circulating blood in both WT and 
Nrf2-/- mice when ethanol was superimposed on LdC diet. This was accompanied by a 
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proportional decrease in circulating lymphocytes. Thus we next performed a cytometric 
analysis of liver resident immune cell populations as previously described(Weston et al., 
2015) and stained for the presence of cells within liver tissue samples. In comparison to 
mice fed LdC alone, both WT and Nrf2-/- mice had a significantly greater proportion of 
CD11b+ cells within the liver after alcohol exposure. When we used F4/80 and Ly6G 
staining to discriminate between neutrophils and macrophages, we observed a significant 
increase in Ly6G+ cell recruitment to the liver after ethanol treatment, particularly in WT 
animals. These cells were distributed throughout the parenchyma (see images in Figure 2B). 
We used cytometric analysis to quantify hepatic myeloid cells (defined by live gating and 
then CD45+CD3-CD11b+as a percentage of total CD45+ cells) and hepatic neutrophils 
(defined by live gating and then CD45+CD3-F4/80-Ly6G+ as a percentage of total CD11b+ 
cells) for WT and Nrf2-/- mice. Hence we observed that the numbers of hepatic CD11b+ 
neutrophils significantly increased after exposure LdC plus ethanol.  In contrast numbers of 
F4/80 positive macrophages/Kupffer cells and their hepatic distribution was unchanged by 
exposure to diet plus ethanol on immunohistochemical quantification (see Figure 2 and 
quantification of staining in Supplementary Figure 3 ). 
Picrosirius red staining of liver sections (Figure 3) also indicated that there was a modest but 
significant accumulation of collagen in mice fed ethanol plus high fat diet at day 15, 
compared to diet alone. This was evidenced by the accumulation of stained collagenous 
fibrils in both the periportal areas and within the parenchyma of alcohol exposed animals. 
Whilst the short duration of our model meant that the extent of staining was modest 
indicative of a very early fibrogenic activation (see images in Figure 3B), it was interesting to 
note that Nrf2-/- mice were more variable in response, and only WT mice showed a 
significant difference between LdC diet alone, and diet plus ethanol (Fig 3A). 
LdC diet and ethanol induces a modest regeneration response  
Chronic exposure to ethanol has been shown to impair the hepatic regeneration 
responses(Wands et al., 1979) with lower numbers of Ki67 positive hepatocytes reported in 
patients with alcohol related cirrhosis compared to other etiologies(Horiguchi et al., 2007). 
This leads to a compensatory ductular reaction in an attempt to restore the functioning 
hepatocyte pool(Dubuquoy et al., 2015) and indeed the extent of this response correlates 
with mortality in patients with alcoholic hepatitis(Gao and Shah, 2015; Sancho-Bru et al., 
2012). To determine whether hepatocyte regeneration was triggered by our acute injury, we 
stained sections from matched anatomical lobes from our mouse livers with Ki67 antibody 
(see representative images in Figure 4) and showed that 15 days exposure to LdC diet plus 
ethanol was sufficient to stimulate hepatocyte proliferation whilst LdC diet alone had no 
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effect. Again although both WT and Nrf2-/- mice exhibited a similar magnitude of response 
upon quantitation, there was significant variation between fields of view within and between 
individual animals. Of note the extent and nature of Ki67 staining was similar at day 17 (see 
representative images in Supplemental Figure 4). 
 
Administration of LdC diet plus ethanol alters hepatic metabolic profile 
To characterise the mechanisms underlying the steatotic response observed in our animals 
we performed a detailed metabolomic characterisation using 1D-NMR on livers from WT 
mice fed either LdC diet alone or LdC diet plus ethanol. Livers were collected over the final 
five days of the protocol. We analysed samples from day 13 and 15, when the degree of 
injury was greatest, and at day 17 when ethanol was no longer present. The LdC diet alone 
sample was collected at Day 17 to allow comparison between chronic effects of diet 
exposure with and without ethanol. Figure 5 shows that we were able to characterize over 
30 metabolites within the samples. These included amino acids, organic acids, 
phospholipids and nucleotides. For clarity these are divided into categories in Figure 5. Of 
note for many groups of metabolites there was a clear trend for increased content in livers 
during peak injury with a gradual return to baseline as ethanol was withdrawn. ANOVA 
confirmed there was a significant effect of ethanol on metabolite content. Intermediates in 
the metabolism of lipids, carbohydrates and amino acids were highest in ethanol-fed animals 
and declined to diet alone levels by day 17. Notable exceptions included maltose and 
formate that tended to increase over time and glucose, lactate and alanine that remained 
more or less static over time. Multiparametric statistical analysis confirmed that for most 
metabolites there is no significant difference between metabolite classes at day 17 on LdC 
alone vs Day 17 after withdrawal of alcohol. Interestingly however amino acid metabolism 
was different, and here at day 17 there is still a significant difference in expression between 
animals exposed to diet alone and those which had received ethanol (Figure 5). 
 
Discussion 
Rodent models of alcoholic hepatitis are of significant importance for new drug discovery in 
an area of unmet clinical need. However, many models don’t recreate all the systemic 
sequlae, fall outside of local regulatory requirements or are technically challenging to 
operate. Hence each model has its own individual challenges and specific advantages 
(reviewed in(Wilkin et al., 2016)). We have based our protocol on one of the most widely 
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used models, the NIAAA binge model(Bertola et al., 2013a) which is similarly easy to 
perform and involves administration of ethanol in a high fat liquid diet with a final binge dose 
of ethanol before collection. This model had no mortality and a reasonable biochemical 
response but there is little hepatic inflammation and no fibrosis demonstrable in mice on this 
protocol(Bertola et al., 2013a).  
This poor recreation of human disease presentation in the most widely used models has led 
to disappointing outcomes in clinical trials. For example there are cases where therapeutic 
anti-inflammatory targets identified as a consequence of rodent studies have not shown 
success when translated into a human setting(Woolbright and Jaeschke, 2018). Recent 
evidence suggested that Nrf2-/- mice are more sensitive to oxidant-mediated injury, and 
exhibit a reproducible alcohol-related injury even on relatively simple dietary administration 
protocols. Nrf2 is a regulator of cellular responses to oxidative stress that is highly 
expressed in the liver where it plays a protective effect in the context of alcohol 
exposure(Sun et al., 2018). Nrf2 -/- mice are more sensitive to the effects of ethanol and 
exhibit exaggerated hypothermic and hypoglycemic responses and reduced capability to 
metabolise acetaldehyde(Sun et al., 2018). They also have a higher mortality on binge 
ethanol models. It is notable therefore that we did not see dramatic differences between 
injury in our wild type vs Nrf2-/-  animals. In the previous study(Lamle et al., 2008) the authors 
used male animals and commenced the protocol with young animals (6-8 weeks). The 
ethanol content of the liquid diet was gradually increased as we did up to a maximum of 
6.3% and administered a single daily ethanol gavage. We observed a similar weight-loss 
and development of steatosis but Lamle et al.,(Lamle et al., 2008) noted that many animals 
became moribund after gavage and also had a significant mortality (all Nrf2-/- animals died by 
day 24). Typical serum ALT levels exceeded 3000IU/L in the Nrf2-/- animals in the Lamle 
study. We did see this in some animals but our mean Nrf2-/- injury peaked at around 
1000IU/L for ALT. We surmise that the difference may relate to the welfare regulations which 
we operate under in the UK. We cannot run experiments to a mortality endpoint and thus 
tended to start our experimental protocol with older, heavier mice (typically 10-12 weeks and 
around 20g). This led to less weight loss as a percentage of starting mass and also meant 
that mice tolerated the gavages and alcohol exposure better. Thus, we would suggest our 
injury was more modest but sustainable. Similarly our use of female animals (in both WT 
and Nrf2-/- groups) likely accounts for the injury in our WT cohort (in contrast to the Lamle 
study(Lamle et al., 2008)). 
Previous studies also suggest that human females have an increased susceptibility to 
alcohol-related liver injury(Eagon, 2010) and female mice tend to consume more alcohol 
than mice on same protocol(Gelineau et al., 2017). Female mice have higher activities of 
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alcohol metabolising enzymes and thus faster rates of ethanol metabolism and clearance 
compared to males(Kishimoto et al., 2002). Female mice have been shown to achieve 
higher plasma alcohol concentration and get more significant steatosis and triglyceride 
increases than males on the same protocol(Wagnerberger et al., 2013). Thus, we 
considered it interesting to see how female WT mice compared to Nrf2-deficient animals on 
our protocol. Our results showed that using a combination of LdC diet +/- EtOH combined 
with more frequent additional EtOH gavage than used in the NIAAA model could reproduce 
many of the key features of alcoholic hepatitis in a murine model. Mice treated with ethanol 
developed a significant elevation in serum transaminases, with significant steatosis and a 
hepatic neutrophil infiltrate. This model is relatively easier to set up than the intragastric 
infusion model described by Tsukamoto et al(Tsukamoto et al., 1985b), and is reasonably 
tolerated - very few mice reached the experimental or humane end-points prior to the 
planned completion date. Our framework for animal use in the UK means we cannot run 
experiments to a mortality endpoint, but we did observe that the small frequency of animals 
which reached the humane endpoints was similar between WT and Nrf2-/- animals. 
Interestingly we did not see significantly greater injury in our female Nrf2-/- mice compared 
to WT females according to the parameters we assessed.  Nevertheless, WT females were 
more reproducible as a group within each analysis than the female Nrf2 mice with virtually 
the same extent of injury. This may reflect the relatively mild injuries imposed by UK ethical 
standards for alcohol models but supports the concept that female mice are particularly 
susceptible to alcohol injury(Wagnerberger et al., 2013) and eliminates the need to use Nrf2-
/- mice. 
In our study, AST and ALT levels were greater than five times the baseline levels with 
AST>ALT. In humans relatively modest increases in serum transaminases are seen in AH 
with AST>ALT a characteristic diagnostic criteria(Botros and Sikaris, 2013). Humans also 
present with elevated bilirubin and hepatic neutrophil infiltration(Woolbright and Jaeschke, 
2018) with fibrosis being a common feature. In agreement with many other models we did 
not see elevated serum bilirubin levels, but our transaminase levels and incipient fibrosis 
stand apart (Woolbright and Jaeschke, 2018). In mice neutrophils normally only constitute 
about 10-25% of peripheral immune cells so our peripheral increases in AH are significant 
and accompanied by a proportional decrease in circulating lymphocytes. This model induces 
increased hepatic recruitment of neutrophils, characteristic of ethanol-mediated liver injury, 
which is a prominent clinical feature of AH in humans and correlates with disease 
prognosis(Degre et al., 2012; Dominguez et al., 2009).Thus we are recreating the picture 
seen in acute human alcoholic hepatitis where the ethanol causes a transient increase in 
circulating myeloid cell populations(Gao et al., 2019) and a profound neutrophil and myeloid 
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cell inflammation in the damaged liver. Indeed the circulating neutrophil: lymphocyte ratio 
has prognostic relevance in alcoholic hepatitis(Forrest et al., 2019). However we did not see 
particularly dense neutrophil infiltrates, abundant ballooning, cholestasis or Mallory-Denk 
bodies(Altamirano et al., 2014), which would characterise severe acute human alcoholic 
hepatitis. This likely relates to the short duration of our injury. It is important to note that we 
have quantified lymphoid and myeloid cells as a proportion of total peripheral blood or 
hepatic immune cells and thus absolute numerical increases in hepatic cells under inflamed 
conditions may be underestimated. However this was sufficient to cause systemic responses 
(weight loss, neutrophilia) and hepatic metabolic changes(Brandl et al., 2018; Ding et al., 
2019; Latchoumycandane et al., 2014) (elevated taurine, lactate and glycerol) that do 
recreate the human picture.  
Previous studies of mice on high fat diet suggest that female animals are more resistant to 
the metabolic sequale of these diets with decreased weight gain, insulin secretion and better 
glucose tolerance than male mice(Gelineau et al., 2017). Thus, separation of effects of 
ethanol as opposed to high fat diet may be easier in female animals. Our model using 
female mice incorporates administration of a Lieber deCarli ethanol diet that contains 
maltose dextrin and escalating concentrations of ethanol. This model causes a predictable 
steatosis driven by increased hepatic free fatty acid uptake, de novo lipogenesis and 
impaired beta oxidation(Warner et al., 2018) and lipolysis, which is rapidly reversed on 
withdrawal of ethanol(Thomes et al., 2019). There appeared to be a tendency for 
metabolites to peak at day 13 and decline therafter, rather than continuing to increase to the 
final day of ethanol exposure at day 15. This may reflect different timepoints of sample 
collection within our small cohorts of animals, as there is a clear diurnal regulation of murine 
metabolism and feeding habits(Weger et al., 2019), which are impacted upon by ethanol 
exposure(Gaucher et al., 2019).  The effect may also be related to time of collection after 
administration of final ethanol gavage. Increased energy availability in mice fed diet plus 
ethanol led to accumulation of fuel for DNL and the tricarboxylic acid (TCA) cycle explaining 
our observed accumulation of lipid in hepatocytes. We also noted that the response was 
rapidly reversable upon withdrawal of ethanol. Impaired carbohydrate metabolism and 
ketoacidosis are a common feature in patients admitted with alcoholic hepatitis(Wrenn et al., 
1991) and features of our murine hepatic metabolic profile suggest we are recreating this 
response.  It is suggested that hepatocytes preferentially use glycerol as a substrate for 
gluconeogenesis(Kalemba et al., 2019) and thus our increase in glycerol may suggest 
impaired glucose generation. This combined with static lactate concentration hints at 
reduced pyruvate generation ability and inhibition of gluconeogenesis. Finally, our increased 
hepatic 3 hyroxybutyrate concentration is suggestive of alcohol-induced 
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ketoacidosis(Srinivasan et al., 2019) and suppression of gluconeogenesis. We observed 
increased accumulation of taurine during ethanol exposure and hepatic and peripheral 
increases in taurine content during ethanol injury have been reported by other groups(Kerai 
et al., 1998). Additionally, taurine can suppress inflammation and reduce oxidative 
stress(Balkan et al., 2002) therefore our hepatic increase may indicate activation of 
hepatoprotective mechanisms. Consequently, our metabolic profiling supports the steatosis 
we observe in mice on diet and fits with the phenotype of patients exposed to alcohol. The 
only notable exception is the increasing hepatic abundance of maltose, which was derived 
from the maltose dextran used in maintenance of isocaloric intake.  
The degree of fibrosis in this model was mild, whereas patients with alcoholic hepatitis often 
exhibit centrilobular pericellular/sclerosing fibrosis which may extend to cirrhosis as a 
consequence of ongoing acute on chronic alcohol-related injury. Unfortunately, advanced 
fibrosis is not reported in any of the murine models of AH. Extending the duration or 
concentration of ethanol administration would potentially induce a more severe fibrosis. 
However, this would be practically difficult within the UK legislative framework because of 
weight loss approaching 20% around day 15.  Other possible methods that could be 
considered to increase the severity of fibrosis include use of carbon tetrachloride injections 
to induce fibrosis, or possibly a longer duration of the LdC diet administration prior to giving 
ethanol. Given our evidence that some degree of hepatocyte regeneration occurs within our 
timeframe (Figure 4) it would also be possible to exacerbate the injury by compromising 
normal regenerative mechanisms during ongoing injury(Raven et al., 2017).  
We originally hypothesized that mice deficient in Nrf2 may show an altered fibrogenic 
response. Whilst Xie et al., report that the Nrf2-Keap-ARE1 pathway protects against 
fibrogenesis(Xie et al., 2018), Hernandez -gea et al., have shown that inhibition of Nrf2 
function in stellate cells reduces their fibrogenic potential(Hernandez-Gea et al., 2013). In 
our hands, the degree of fibrosis assessed by PSR staining was not significantly different 
between WT and Nrf2-/- mice on LdC plus EtOH protocol, which suggests that, at least in this 
model the role is minimal. However, we did note that the significant increase we observed in 
PSR staining between LdC alone and LdC+ethanol in WT mice was not recreated in the 
Nrf2-/- mice (i.e there was similar extent of staining in both conditions) this may suggest that 
the Nrf2 deficiency has indeed modified stellate cell activation. Persistent activation of Nrf2-/- 
in a situation of impaired hepatic autophagy is important for inflammation, fibrogenesis and 
apoptosis and is linked to tumorigenesis (Ni et al., 2014). Although deficiency in Nrf2 may 
increase reactive oxygen species (ROS) induced hepatic damage, and thus has been linked 
to more severe alcohol-dependent injury in some models(Lamle et al., 2008), it may be 
unwise to use these mice when modelling injuries linked to fibrogenesis or longer term liver 
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injury. Anecdotally we also noted that the Nrf2-/- mice tended to be more aggressive, or at 
least to show diminished healing responses to injuries sustained in territorial fights. This is in 
keeping with reports of impaired wound healing responses in this strain(Li et al., 2019; Long 
et al., 2016) and influenced our opinions on the relative merits of this strain for modelling 
alcohol injury.However, we would note that the responses we have observed were 
generated from relatively small cohorts of animals housed in our specific facility and thus it is 
possible that using increased numbers of animals or those housed in alternate colonies may 
explain differential sensitivities of the Nrf2 strain in different models. 
There are a number of challenges of modelling human alcoholic hepatitis using mice. The 
alcohol catabolism rate is up to five-times higher in rodents compared to humans and the 
amount of ethanol administered to animals to achieve sustained blood alcohol concentration 
and subsequent liver injury cannot be directly compared with human alcohol 
consumption(Holmes et al., 1986). In a time course experiment, we found that upon 
withdrawal of ethanol at day 15 of this protocol, mice had normalisation of serum 
transaminases and were gaining weight again by day 17. Similarly, our reported metabolic 
changes began to normalise by day 17. Such rapid resolution of liver injury would not be 
typical of patients with severe alcoholic hepatitis. However, our use of female wild type mice 
has recreated many of the key features of human alcoholic hepatitis and thus has potential 
for improving our understanding of the proinflammatory, profibrotic and metabolic 
disturbances that characterise human disease.  
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Figure 1: Mice treated with modified LdC diet and ethanol exhibit weight loss, 
inflammation and hepatic steatosis.  
WT and Nrf2-/- mice were fed LdC diet only for 5 days. At day 6 experimental groups 
received 2.2% EtOH mixed into the LdC diet. This was increased to 4.4% at day 9, and to 
6.3% at day 12. Additionally, experimental groups received twice daily ethanol gavage of 
33% EtOH (LdC+EtOH).  Control mice received LdC diet only throughout the experiment 
and were not gavaged. (A) left graph indicates mean mouse weight ±SEM in gram (g). 
Linear regression analysis confirmed significant weightloss in WT and Nrf2-/- mice on 
LdC+EtOH (p< 0.01 for both). Representative H&E stained liver sections from WT and Nrf2-/- 
mice fed normal chow, LdC or LdC+EtOH are shown (Right images). Scale bar is at 50μm, 
data is representative of at least n=6 animals per group.  (B) Serum was prepared from WT 
and Nrf2-/- mice at day 15 for determination of ALT concentration. Symbols are values from 
individual mice and bars are mean ±SEM for the group. Statistical difference level is 
indicated by * for p<0.05 and ** for p<0.01 performed with the Kruskal-Wallis Dunn’s multiple 
comparison test. (C) Haematoxylin and eosin stained sections were scored semi-
quantitatively for the grade steatosis on a scale of 0-3. Symbols are values from individual 
mice and bars indicate mean ±SEM for each group. Statistical difference level is indicated by 
* for p<0.05 and ** for p<0.01 performed with the Kruskal-Wallis Dunn’s multiple comparison 
test. (D) Haematoxylin and eosin stained sections were scored for inflammation using overall 
grade (1-3). Symbols are values from individual mice and bars represent mean ± SEM of the 
group.  
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Figure 2: Injured WT and Nrf2-/- mice demonstrate alterations in peripheral and hepatic 
immune cell populations.  A) Following cardiac puncture EDTA anti-coagulated blood was 
passed through an automated blood count analyser and neutrophil, monocyte and 
lymphocyte counts are presented as a percentage of WBC (white blood cells). Symbols are 
values from individual mice and bars represent mean ± SEM of the group . Statistical 
difference level is indicated by * for p<0.05 and ** for p<0.01 performed with the Kruskal-
Wallis Dunn’s multiple comparison test. B) Left Images : FFPE liver tissue was sectioned 
(5µm) and stained with anti-CD45, or Ly6G antibodies. In addition, liver lobes from mice fed 
with LdC or LdC+EtOH were collected at day 15 and digested for cytometric analysis (right 
graphs).  Images are representative of multiple fields of view in n = 4-7 animals per group. 
Graphs show cytometric quantitation of myeloid cells (defined by live gating and then 
CD45+CD3-CD11b+as a percentage of total CD45+ cells) and hepatic neutrophils (defined by 
live gating and then CD45+CD3-F4/80-Ly6G+ as a percentage of total CD11b+ cells) for WT 
and Nrf2-/- mice. Bars represent mean ± SEM of the group (n=4-7 individual livers per 
group. Statistical differences were assessed using Mann-Whitney test *p < 0.05, **p < 0.01. 
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Figure 3: Mice receiving LdC diet and ethanol show signs of early fibrosis at day 15.  
FFPE liver tissue was sectioned (5µm) and stained with picrosirius red. For quantification 5-
6 random fields of view per section were imaged and processed with ImageJ software. Data 
are expressed as the percentage of the total area of the section occupied by Sirius red 
staining. A) Average picrosirius red stained area in indicated groups of mice. Symbols are 
values from individual mice and bars represent mean ±SEM of the group. Statistical 
difference level is indicated by * for p<0.05 performed with Kruskal-Wallis Dunn’s multiple 
comparison test. B) Representative images of picrosirius red-stained liver sections from WT 
and Nrf2-/- mice fed normal chow, LdC or LdC+EtOH are shown. Scale bar is at 50μm, data 
is representative of at least n=3 animals per group.  
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Figure 4: Ethanol induces an increase in hepatocyte proliferation. FFPE liver tissue 
was sectioned (5µm) and stained with Ki67 antibody to identify proliferating cells. 
Representative images of Ki67 stained liver sections from WT and Nrf2-/- mice fed normal 
chow, LdC or LdC+EtOH are shown. Scale bar is at 100μm, data is representative of at least 
n=4 animals per group. For quantification 5-6 random fields of view per section were imaged 
and processed with ImageJ software. Data was expressed as number of Ki67 positive 
hepatocytes per field of view.  
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 Figure 5: Exposure to ethanol-containing diet induces a transient change in 
hepatocyte energy metabolism. Polar metabolites were extracted from frozen liver lobes 
from animals exposed to LdC diet alone at day 17 (LdC) or LdC diet plus ethanol at days 13, 
15 and 17. Data are averages of multiple samples prepared from single animals in the 
control groups and 3-4 animals on alcohol diets. All spectra were acquired at 300 K on a 
Bruker 600 MHz spectrometer with a TCI 1.7mm z-PFG cryogenic probe using a cooled 
Bruker SampleJet autosampler. 1D 1H NMR spectra were processed using the NMRlab and 
Metabolab programmes within Matlab, version R2016b (MathWorks, Massachusetts, USA).  
Resonances were assigned using Chenomx (Alberta, Canada, 2015). Assigned peaks were 
then integrated in all spectra and metabolite intensities were compared between mice 
exposed to diet alone and LdC diet plus ethanol exposed samples on indicated days. Data 
are mean ± SEM of the group and have been divided into indicated categories of 
metabolites. Effects of diet were compared using two-way ANOVA which confirmed that for 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
all classes of metabolite there was a significant effect of diet on intensity of signal (p<0.001 
for all metabolites). Tukey’s multiple comparison test to compared individual diets. Here for 
all classes of metabolite control LdC was significantly different than day 13 and day15 
timepoints on LdC plus ethanol. All metabolites except for BCAA and AAA metabolism were 
not significantly different in LdC and LdC plus EtOH at day 17 (for BCAA and AAA p<0.001 
LdC vs LdC+EtOH at day 17). 
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Tables 
Table 1 : Constituents of ad libitum alcohol diet administered to experimental animals 
Ethanol % 
in the diet 
(vol/vol) 
Dry mix 
(g) 
Maltose 
dextrin (g) 
Water 
(ml) 
95% 
ethanol 
(ml) 
Calories 
from 
maltose 
dextrin (%) 
Calories 
from 
ethanol 
(%) 
0 133 91.3 900 0 35.5 0 
2.1% 133 62.9 910 21.1 24 11.5 
4.2% 133 34.5 920 42.2 12.5 23 
6.3% 133 6.1 930 63.3 1 34.5 
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Table 2: Antibodies used for flow cytometry  
Antibody Clone Source and 
catalogue 
number 
Fluorochrome Stock 
Conc 
Final Dilution 
Lymphoid Master Mix   
CD49b DX5 Biolegend 
108913 
FITC 0.5mg/ml 1:200 
CD19 ID3 E-bioscience  
25-0193-82 
PE-Cy7 0.2mg/ml 1:100 
CD8A 53-6.7 E-bioscience 
45-0081-80  
PERCYP5.5 0.2mg/ml 1:100 
CD4 GK1.5 E-bioscience 
17-0041-81 
APC 0.2mg/ml 1:100 
CD3 17A2 E-bioscience 
558214 
E450 0.2mg/ml 5:200 
CD45 30-F11 E bioscience 
563891 
BV510 0.2mg/ml 1:50 
Myeloid Master Mix   
Ly6C HK1.4 E-bioscience 
12-5932-82 
PE 0.2mg/ml 1:600 
Ly6G 1a8-
Ly6G 
E bioscience 
17966882 
APC 0.5mg/ml 1:300 
CD45 30-F11 Biolegend 
103132 
PERCYP5.5 0.2mg/ml 1:200 
CD11b M1/70 E-bioscience 
11-0112-82 
FITC 0.5mg/ml 1:100 
CD3 17A2 E-bioscience 
558214 
E450 0.2mg/ml 5:200 
F4/80 Bm8 E-bioscience 
25-4801-82 
PE-Cy7 0.2mg/ml 1:50 
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Table 3 : Antibodies used for immunochemistry 
Primary antibody Secondary Antibody Isotype control 
Anti-Ly6G (e-bioscience rat anti-
mouse ab 0.5mg/ml (clone RB6-
8C5) used at 1:500 dilution) 
ImmPRESS peroxidase anti-rat kit 
(Vector Labs) 
Rat IgG2a  (e-bioscience- 
eBR2a used at 1:500) 
Anti-F4/80 rat anti-mouse ab (E-
biosciences 14-4801) 0.5mg/ml 
used at 1:200 dilution 
ImmPRESS peroxidase anti-rat kit 
(Vector Labs) 
Rat IgG2a (e-biosciences 
eBR2a used at 1:200) 
Anti-Ki67 rabbit anti-mouse ab 
from Abcam (ab16667) clone SP6 
used at 1:200 dilution 
Horse anti-rabbit antibody from 
Vector Laboratories (BA1100) 
BA1000 anti-rabbit IgG (H+L) 
Anti-CK19 rat anti-mouse 
monoclonal ab from DSHB 
100ug/ml used at 1:250 dilution 
ImmPRESS peroxidase anti-rat Rat IgG2a (e-biosciences 
eBR2a used at 1:250) 
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Figure S1 : Serum biochemical analysis from mice treated with 
modified LdC diet and ethanol WT and Nrf2-/- mice were fed LdC diet 
only for 5 days. At day 6 experimental groups received 2.2% EtOH 
mixed into the LdC diet. This was increased to 4.4% at day 9, and to 
6.3% at day 12. Additionally, experimental groups received twice daily 
ethanol gavage of 33% EtOH (LdC+EtOH).  Control mice received LdC 
diet only throughout the experiment and were not gavaged. Serum was 
prepared from WT and Nrf2-/- mice at day 15 for determination of ALST 
and AP concentration. Symbols are values from individual mice and 
bars are mean ±SEM for the group. Statistical difference level is 
indicated by * for p<0.05 and ** for p<0.01 performed with the Kruskal-
Wallis Dunn’s multiple comparison test.
Supplemental Figure 1
Disease Models & Mechanisms: doi:10.1242/dmm.046383: Supplementary information
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Supplemental Figure 2
Figure S2: Mice fed ethanol-containing diet demonstrate significant liver steatosis. 
Accumulation of lipid droplets in hepatocytes within murine liver tissue sections was assessed by 
Oil red O staining. (A) Representative Oil Red O-stained liver sections from WT and 
Nrf2-/- mice fed normal chow, LdC or LdC+EtOH are shown. Scale bar is 50μm, data is 
representative of at least n=4 animals per group. (B) Quantification of extent of Oil Red O staining. 
Data form multiple fields of view per animal were captured using ImageJ and are expressed as a 
percentage of surface area occupied by lipid. Symbols are values from individual mice and bars 
represent mean ±SEM of the group. Statistical difference level is indicated by ** for p<0.01 or 
***p<0.001 based on Kruskal-Wallis Dunn’s multiple comparison test. 
Disease Models & Mechanisms: doi:10.1242/dmm.046383: Supplementary information
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Figure S3: Staining for F4/80 positive cells suggests no change in number after exposure to 
ethanol. A : Representative images of F4/80+ cells in liver sections from WT and 
Nrf2-/- mice fed chow or LdC+EtOH as indicated, representative of at least n=3 animals per group. 
(B and C) Quantification of extent of F480 or Ly6G staining. Data from multiple fields of view per 
animal were captured using ImageJ and are expressed as a percentage of surface area occupied by 
F4/80 staining or number of Ly6G positive cells per field.Symbols are mean values from individual 
mice and bars represent mean ±SD of the group. Statistical difference level is indicated by ** for 
p<0.01 based on Kruskal-Wallis Dunn’s multiple comparison test. 
Disease Models & Mechanisms: doi:10.1242/dmm.046383: Supplementary information
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